biospace med, a Paris, France-based developer of a new medical imaging modality that allows full-body 2D and 3D imaging of patients, has raised $18m in venture capital funding.
The round included existing investors Edmond de Rothschild Investment Partners (Paris), Crédit Agricole Private Equity (Paris), UFG Private Equity (Paris), NBGI Ventures (London), COFA Invest (Paris), as well as new investor CDC Entreprises, acting on behalf of the SIF (Strategic Investment Fund).
The new capital will enable the company to accelerate market expansion in North America and Europe of its FDA-cleared EOS ultra-low-dose 2D/3D imaging system, an innovative solution to reduce irradiation linked to radiological investigations, which has risen by 600% over the past twenty years.
The company currently has approximately 40 employees, and has a subsidiary in Cambridge, Massachusetts, USA, as well as an office in Montreal (Canada).
FinSMEs
13/04/2010